RECRUITING

Interoceptive Exposure for Adolescents With Low Weight Eating Disorders

Description

This project includes a parallel group randomized controlled trial comparing two psychological treatments: 1) Exposure-based Family Therapy (IE) vs. 2) Family Based Therapy (FBT) for low weight eating disorders with 12 month follow-up. Primary outcomes are expected body weight and clinical impairment. Three mechanisms of change (Autonomous Eating, Non-Judgmental Body Awareness, and Extinction Learning) will be examined in a process mediation models of change.

Study Overview

Study Details

Study overview

This project includes a parallel group randomized controlled trial comparing two psychological treatments: 1) Exposure-based Family Therapy (IE) vs. 2) Family Based Therapy (FBT) for low weight eating disorders with 12 month follow-up. Primary outcomes are expected body weight and clinical impairment. Three mechanisms of change (Autonomous Eating, Non-Judgmental Body Awareness, and Extinction Learning) will be examined in a process mediation models of change.

A Confirmatory Efficacy Study of Interoceptive Exposure for Adolescents With Low Weight Eating Disorders

Interoceptive Exposure for Adolescents With Low Weight Eating Disorders

Condition
Anorexia Nervosa
Intervention / Treatment

-

Contacts and Locations

New York

Department of Psychiatry, Eating and Weight Disorders Program, New York, New York, United States, 10028

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Aged 12-18
  • * Speak English
  • * Permission from pediatrician or equivalent to receive outpatient care
  • * Clinically significant restriction of food intake by EDA-5 or evidence of persistent food avoidance from patient or guardians
  • * Evidence of the inability to maintain greater than minimally low body weight based on BMI for age percentiles and growth trajectories
  • * Comorbid psychotic or bipolar disorder
  • * Active suicidal ideation
  • * Current substance dependence
  • * Psychiatric medication initiated or dosage changes \<2 weeks from baseline
  • * Major medical illness (e.g., diabetes mellitus, Crohn's disease, etc.)

Ages Eligible for Study

12 Years to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Icahn School of Medicine at Mount Sinai,

Thomas Hildebrandt, Psy.D., PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai

Study Record Dates

2028-01